FIELD: medicine, ophthalmology. SUBSTANCE: invention proposes a composition at the following ratio of components, wt.-%: acycloguanosine, 1.0-5.0; aubazidan, 0.3-1.0; boric acid, 1.6-2.0; nipagin, 0.07-0.14; propyl-para-hydroxybenzoate, 0.03-0.06; and purified water, the balance. Composition is used for treatment of different forms of ophthalmoherpes. EFFECT: enhanced effectiveness of composition. 6 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG | 1996 |
|
RU2120294C1 |
| METHOD FOR TREATING THE CASES OF ULCERATED HERPETIC KERATITIS | 2001 |
|
RU2192898C1 |
| ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
| GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
| ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
| EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
| EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
| METHOD OF TREATING ULCERATED HERPETIC KERATITIS | 1996 |
|
RU2122844C1 |
| METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
